Addressing Non-Ventilator-Associated Hospital-Acquired Infection Prevention.
Recent healthcare polices, such as the Center for Medicare and Medicaid Services (CMS) SEP-1, have not focused on the impact of non-ventilator-associated hospital-acquired infections (NV-HAP) on sepsis rates. With a 36.3% sepsis rate in NV-HAP patients compared to 1.9% in those with community-acquired pneumonia, NV-HAP sees staggering 19-fold increase in sepsis incidence.
Meanwhile, sepsis treatment in the U.S. costs the industry $24 billion annually, so more proactive steps toward prevention could not only mean healthier patients, but better financial outcomes as well.
Sponsored by:
By downloading this resource, I agree to sign up to receive newsletters and special offers from PSQH and the sponsor. I understand that I can opt-out at any time. Privacy policy.